The Neuromuscular Disease Network for Canada (NMD4C) together with Muscular Dystrophy Canada (MDC) are pleased to invite you to a webinar on updates in Duchenne muscular dystrophy (DMD): present and future perspectives – therapeutic strategies, treatment possibilities and outcomes.

This webinar is primarily targeted at Canadian clinicians, academics, and trainees with an interest in neuromuscular disease.

NMD4C and MDC are providing organizational and technical support. This is an independent clinical/academic webinar. Hoffmann La-Roche has kindly provided support for this webinar, but there is no involvement and influence from the industry partner on the content and delivery of the information.

Chair:

Dr. Kathryn Selby, Clinical Assistant Professor, UBC | Pediatric Neurologist and Investigator, BC Children’s Hospital

Agenda & Speakers:

Dr. Craig Campbell: DMD therapy development and next generation exon skipping drugs

Dr. Hernan Gonorazky: Hurdles and opportunities in gene replacement therapy for DMD

Dr. Jordan Sheriko: CNDR and DMD registry update – From clinical trial readiness to real world evidence

Learning Objectives:

• To understand the current advances, challenges and opportunities in gene therapy for DMD in Canada
• To understand how molecular mechanisms may influence genetic profile and phenotype in DMD
• The changing needs and value of the registry in DMD

Register at: https://bit.ly/DMDMar7

If you have any questions, please email

The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.